New Harbor Capital has completed a majority equity investment in LGM Pharma, a company involved in distribution of cGMP active pharmaceutical ingredients (“API”) and other value-added services supporting leading pharmaceutical companies.    “New Harbor’s strong track record of successfully executing growth strategies, as well as their experience with the healthcare industry and pharmaceutical services, will elevate our business to the next level while upholding the high quality, in...